|
[ Faculty_&_Fellows ]
[ The_Endocrine_System ]
[ Gonda_Diabetes_Center ]
[ Fellowship ]
[ Endocrine_Clerkship ]
[ Endocrinology_Resources ]
[ Resources_For_Patients ]
[ Administration ]
|
The Division
of Endocrinology, Diabetes, and Hypertension Research Programs
|
The Gonda Diabetes Center, directed by Dr.
Andrew Drexler, M.D., located at the 200 UCLA Medical Plaza, Suite 530, is
a state-of-the-art facility offering high quality care for patients with
diabetes and any other endocrine disorder.
|
|
The Hillblom_Islet_Research_Center,
directed by Dr. Peter Butler, M.D., located at 900A Weyburn Place North, brings together a group of leading scientists to work
as a team in the area of islet research. The team includes experts in the
understanding of why islet cells are killed and how this outcome might be
avoided, how islet cells are formed and how we might encourage islet
repair, how islet cells make and release insulin, and how this process
might be increased to restore insulin levels. In the Hillblom Islet
Research Center, collaborating investigators have the benefit of conducting
their research with state-of-the-art equipment and facilities. This superb
environment was made possible by a grant from the Larry L. Hillblom
Foundation. The research team in the Islet Research Center strives to
provide excellent training for young scientists from around the world, and
in so doing, to understand the cause of islet cell destruction leading to
diabetes and to understand how islet cells can be replaced that eventually
will lead to the prevention and cure of diabetes.
|
|
The Blood Brain Barrier Research Laboratory,
directed by Dr. William Pardridge, Ph.D., located at 900 Weyburn Place North, Suite 13-164 Warren Hall, focuses on the biological
basis of targeted delivery through the blood-brain barrier (BBB) of protein
and gene therapeutics. Progress in this difficult area requires the merger
of animal neurophysiology, pharmacokinetics, and molecular biology. The
laboratory is developing new approaches for the treatment of stroke with
neurotrophins, new approaches to imaging gene expression in vivo with
antisense radiopharmaceuticals, new approaches to the non-invasive,
non-viral targeting of gene medicines to the brain, genetic engineering and
"humanization" of monoclonal antibodies, and "BBB
genomics", or the discovery of novel genes selectively expressed at
the BBB.
|
Contact information for
suggestions or comments about our website or its contents.
Postal
Address:
Division of Endocrinology,
Diabetes and Hypertension
UCLA Department of Medicine
24-130 Warren Hall
900 Veteran Avenue
Los Angeles, CA 90095-7073
Telephone: (310) 794-7555
Fax: (310) 794-7654
Email: ffabunan@mednet.ucla.edu
|
Division of Endocrinology, Diabetes and Hypertension